Reliance
RS
396.22
-5.27
-1.31%
Reliance
US · RS
#937 by market cap
Listed 1970
396.22
-5.27
-1.31%
Live - 5344 symbols - heartbeat 205s ago
· 2026-10-08 08:30
Pre-market
395.49
-0.18%
After-hours
396.22
0.00%
- Market cap
- 20.23B
- P/E (TTM)i
- 23.02
- P/Bi
- 2.73
- EPSi
- 13.98
- Div yieldi
- 1.24%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on RS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.86, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.32% YoY
Margins
- Gross margin
- 28.74%
- Operating margin
- 7.02%
- Net margin
- 5.17%
Key ratios & quality
- Enterprise valuei
- 21.50B
- Altman Z-Scorei
- 6.86
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.53B | 10.97B | 8.81B | 14.09B | 17.03B | 14.81B | 13.84B | 14.29B |
| Gross profit | 3.28B | 3.33B | 2.78B | 4.49B | 5.25B | 4.55B | 4.11B | 4.11B |
| Selling & admin expenses | 2.10B | 2.11B | 1.89B | 2.32B | 2.52B | 2.58B | 2.68B | 2.83B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 962.40M | 1.00B | 660.40M | 1.94B | 2.49B | 1.72B | 1.15B | 1.00B |
| Pretax profit | 850.60M | 929.30M | 478.20M | 1.88B | 2.43B | 1.74B | 1.14B | 969.20M |
| Tax | 208.80M | 223.20M | 105.80M | 465.70M | 586.20M | 400.60M | 261.90M | 227.60M |
| Net profit | 641.80M | 706.10M | 372.40M | 1.42B | 1.84B | 1.34B | 878.00M | 741.60M |
| Basic EPS | 9 | 10 | 6 | 22 | 30 | 23 | 16 | 14 |
| Diluted EPS | 8.75 | 10.34 | 5.66 | 21.97 | 29.92 | 22.64 | 15.56 | 13.98 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.48B | 3.66B | 3.65B | 3.50B | 4.03B | 4.63B |
| Gross profit | 1.03B | 1.09B | 1.03B | 954.70M | 1.17B | 1.30B |
| Selling & admin expenses | 690.20M | 706.00M | 701.30M | 728.00M | 734.80M | 789.40M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 274.40M | 312.20M | 259.80M | 157.40M | 367.90M | 441.60M |
| Pretax profit | 262.40M | 304.30M | 247.70M | 154.80M | 349.50M | 429.80M |
| Tax | 61.90M | 70.10M | 57.70M | 37.90M | 83.90M | 106.20M |
| Net profit | 200.50M | 234.20M | 190.00M | 116.90M | 265.60M | 323.60M |
| Basic EPS | 4 | 4 | 4 | 2 | 5 | 6 |
| Diluted EPS | 3.74 | 4.42 | 3.59 | 2.22 | 5.10 | 6.29 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.29B | 3.01B | 3.11B | 4.16B | 4.89B | 4.77B | 3.90B | 4.14B |
| Cash & ST investments | 128.20M | 174.30M | 683.50M | 300.50M | 1.17B | 1.08B | 318.10M | 216.60M |
| Inventory | 1.82B | 1.65B | 1.42B | 2.07B | 2.00B | 2.04B | 2.03B | 2.19B |
| Total assets | 8.04B | 8.13B | 8.11B | 9.54B | 10.33B | 10.48B | 10.02B | 10.37B |
| Total current liabilities | 699.10M | 675.30M | 613.00M | 1.07B | 1.38B | 843.60M | 1.21B | 848.10M |
| Short-term debt | 65.20M | 117.40M | 57.00M | 63.60M | 560.70M | 56.50M | 461.10M | 68.40M |
| Long-term debt | 2.14B | 1.52B | 1.64B | 1.64B | 1.14B | 1.14B | 742.80M | 1.42B |
| Total liabilities | 3,365,400,000.00 | 2,917,000,000.00 | 2,984,100,000.00 | 3,442,300,000.00 | 3,234,000,000.00 | 2,747,500,000.00 | 2,791,200,000.00 | 3,193,800,000.00 |
| Total equity | 4.68B | 5.21B | 5.12B | 6.09B | 7.10B | 7.73B | 7.23B | 7.18B |
| Retained earnings | 4.64B | 5.19B | 5.19B | 6.16B | 7.17B | 7.80B | 7.33B | 7.26B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.21B | 4.29B | 4.36B | 4.14B | 4.57B | 4.92B |
| Cash & ST investments | 277.80M | 239.50M | 261.20M | 216.60M | 249.70M | 235.40M |
| Inventory | 2.11B | 2.25B | 2.31B | 2.19B | 2.23B | 2.33B |
| Total assets | 10.37B | 10.49B | 10.55B | 10.37B | 10.81B | 11.17B |
| Total current liabilities | 1.33B | 1.35B | 984.00M | 848.10M | 1.04B | 1.15B |
| Short-term debt | 462.80M | 464.20M | 64.80M | 68.40M | 69.20M | 67.30M |
| Long-term debt | 1.07B | 1.03B | 1.38B | 1.42B | 1.69B | 1.66B |
| Total liabilities | 3,251,400,000.00 | 3,245,900,000.00 | 3,233,900,000.00 | 3,193,800,000.00 | 3,677,200,000.00 | 3,754,000,000.00 |
| Total equity | 7.11B | 7.24B | 7.32B | 7.18B | 7.13B | 7.41B |
| Retained earnings | 7.21B | 7.32B | 7.40B | 7.26B | 7.22B | 7.48B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 664.60M | 1.30B | 1.17B | 799.40M | 2.12B | 1.67B | 1.43B | 831.40M |
| Depreciation & amortization | 215.20M | 219.30M | 227.30M | 230.20M | 240.20M | 245.40M | 268.70M | 278.20M |
| Free cash flow | 424.70M | 1.06B | 1.00B | 562.80M | 1.78B | 1.20B | 999.20M | 502.50M |
| Dividends paid | -145.30M | -151.30M | -164.10M | -177.00M | -217.10M | -238.10M | -249.70M | -254.70M |
| Stock buybacks / issuance | -484.90M | -50.00M | -337.30M | -323.50M | -630.30M | -479.50M | -1.09B | -594.10M |
| Ending cash balance | 128.20M | 174.30M | 683.50M | 300.50M | 1.17B | 1.08B | 318.10M | 216.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 64.50M | 229.00M | 261.80M | 276.10M | 151.40M | 162.20M |
| Depreciation & amortization | 68.70M | 69.70M | 70.50M | 69.30M | 69.20M | 69.50M |
| Free cash flow | -22.40M | 141.40M | 180.60M | 202.90M | 87.20M | 68.80M |
| Dividends paid | -65.20M | -63.10M | -62.90M | -63.50M | -66.60M | -63.80M |
| Stock buybacks / issuance | -253.20M | -79.90M | -60.90M | -200.10M | -234.20M | 0 |
| Ending cash balance | 277.80M | 239.50M | 261.20M | 216.60M | 249.70M | 235.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.57 | 14.20 | 7.15 | 25.23 | 27.94 | 18.04 | 11.71 | 10.28 |
| ROA %i | 8.02 | 8.67 | 4.55 | 16.02 | 18.53 | 12.84 | 8.54 | 7.25 |
| ROIC %i | 11.18 | 11.85 | 6.87 | 20.44 | 23.07 | 15.68 | 10.94 | 9.83 |
| 5-year avg ROE %i | 10.43 | 11.40 | 11.28 | 14.81 | 17.62 | 18.51 | 18.01 | 18.64 |
| EBIT margin %i | 8.73 | 9.92 | 7.04 | 14.41 | 15.18 | 12.69 | 9.28 | 7.93 |
| FCF / sales %i | 3.68 | 9.65 | 11.36 | 3.99 | 10.44 | 8.12 | 7.22 | 3.52 |
| Current ratioi | 4.70 | 4.46 | 5.08 | 3.91 | 3.55 | 5.66 | 3.21 | 4.88 |
| Quick ratioi | 1.98 | 1.89 | 2.63 | 1.86 | 2.02 | 3.07 | 1.42 | 2.11 |
| Debt / assetsi | 27.39 | 22.02 | 22.82 | 19.59 | 18.06 | 13.14 | 14.15 | 16.77 |
| LT debt / equityi | 45.78 | 32.13 | 35.05 | 29.65 | 18.41 | 17.10 | 13.26 | 23.31 |
| Interest coveragei | 6.44 | 6.85 | 4.36 | 13.71 | 16.79 | 13.57 | 8.93 | 6.87 |
| Revenue CAGR (3Y) %i | 7.25 | 8.41 | -3.22 | 6.91 | 15.76 | 18.88 | -0.61 | -5.66 |
| Net income CAGR (3Y) %i | 26.71 | 32.10 | -15.58 | 30.64 | 37.91 | 53.54 | -14.76 | -26.21 |
| FCF CAGR (3Y) %i | -20.74 | 30.96 | 61.55 | 9.84 | 18.82 | 6.30 | 21.09 | -34.36 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.27 | 9.93 | 9.94 | 10.28 | 11.31 | 12.21 |
| ROA %i | 7.33 | 7.05 | 6.99 | 7.25 | 7.60 | 8.25 |
| ROIC %i | 9.73 | 9.50 | 9.47 | 9.83 | 10.37 | 11.16 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.42 | 8.11 | 7.91 | 7.93 | 8.26 | 8.57 |
| FCF / sales %i | 7.01 | 6.08 | 4.76 | 3.52 | 4.13 | 3.41 |
| Current ratioi | 3.17 | 3.18 | 4.43 | 4.88 | 4.39 | 4.30 |
| Quick ratioi | 1.47 | 1.42 | 1.97 | 2.11 | 2.11 | 2.13 |
| Debt / assetsi | 16.98 | 16.51 | 16.01 | 16.77 | 18.77 | 17.87 |
| LT debt / equityi | 18.27 | 17.53 | 22.23 | 23.31 | 27.51 | 26.05 |
| Interest coveragei | 7.91 | 7.40 | 7.17 | 6.87 | 7.25 | 7.84 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Carbon steel is the largest reported line at 56.62% of revenue, across 7 reported segments.
- Aluminum follows at 18.10%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Carbon steel56.62%
Aluminum18.10%
Stainless steel12.86%
Alloy4.02%
Toll processing and logistics3.96%
Copper and brass2.67%
Miscellaneous and eliminations1.77%
Quote time 2026-10-08 08:30:07 · For reference only, not investment advice and not tailored to your situation.